Share this article and save a life!
FDA just unleashed the biggest AI healthcare revolution in history.
On January 6, 2026, FDA announced sweeping deregulation that fundamentally changes how AI reaches patients.
The details are stunning:
📱 General wellness apps and wearables: No longer regulated if they don’t make medical claims
🤖 Clinical decision support AI: Many tools now completely exempt from FDA review
💬 ChatGPT-style health tools: Classified as information sources, not medical devices
🚀 The TEMPO pilot: Digital health companies can treat Medicare patients before full FDA approval
Here’s what this means for healthcare:
The FDA is creating a two-track system. Low-risk AI tools that provide information or support clinical decisions can now reach market immediately. No 510(k). No lengthy reviews. Just launch.
Meanwhile, diagnostic and treatment AI still faces oversight, but through streamlined pathways that emphasize real-world outcomes over theoretical risks.
This shift recognizes a critical reality: The traditional medical device framework was strangling innovation. While FDA spent months reviewing step counters, patients couldn’t access potentially life-saving AI tools.
But here’s the tension:
We’re essentially running a massive real-world experiment. Millions will use unregulated AI health tools. Some will benefit tremendously. Others may face risks we haven’t anticipated.
The market, not regulators, will now determine which AI tools succeed. Patient outcomes and provider adoption will separate valuable innovations from digital snake oil.
For health systems, this changes everything. You can now deploy AI decision support without regulatory barriers. Your biggest challenge shifts from compliance to validation: Which tools actually improve care?
For startups, the gates are open. But with freedom comes responsibility. Without FDA’s seal of approval, you’ll need robust evidence and stellar outcomes to earn trust.
The most fascinating part? FDA is tying reimbursement to outcomes through the ACCESS model. Get paid for results, not just clearance. That’s revolutionary thinking from a traditionally conservative agency.
We’re witnessing healthcare’s iPhone moment. When Apple launched the App Store, they didn’t regulate every app. They created a platform and let innovation flourish.
FDA just did the same for healthcare AI.
The question isn’t whether this will transform medicine. It’s whether our health systems, providers, and patients are ready for the tsunami of AI tools heading their way.
♻️ Repost if healthcare AI should prioritize innovation over regulation.
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
